Want to join the conversation?
During 1Q16, $XRX's effective tax rate was 93.8%. On an adjusted basis, 1Q16 tax rate was 22.5%, which was lower than the US statutory tax rate mainly due to foreign tax credits resulting from anticipated dividends from the company's foreign subsidiaries and the geographical mix of profits.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.